Abigail Brooks, MA

The FDA updates acetaminophen warnings for pregnant women and approves leucovorin for treating cerebral folate deficiency.

The findings of the study suggest HS is associated with pregnancy complications and adverse outcomes for both mothers and offspring.

A study of over 1 million births in Quebec reveals that pregnant women with hidradenitis suppurativa face increased risks of pregnancy complications and long-term health issues for both themselves and their offspring.

A recent study reveals that individuals with rheumatoid arthritis face a higher risk of stroke and stroke-related mortality, with notable differences between men and women.

A recent study from France demonstrates that incorporating hepatitis C virus screening into breast cancer programs significantly improves patient engagement and access to effective antiviral treatments among older women.

A comprehensive analysis reveals rising hospitalization rates among pregnant women with hepatitis C virus, with age as a critical factor influencing maternal and fetal health outcomes.

Pregnant women in rural Appalachia face an 11.94% hepatitis C virus infection rate—5 times the state average—revealing a pressing public health concern that demands increased treatment opportunities.

The presence of NAFLD increased from 25.3% to 29.4% among patients receiving oral menopause hormone therapy.